Thu 24 Sep 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Updated Section | Month |
|---|---|---|---|
| Vemurafenib | Zelboraf | 4.8 Undesirable effects | Aug ,2026 |
| Teplizumab | Tzield | 4.8 Undesirable effects | Aug ,2026 |
| Teduglutide | Revestive | 4.8 Undesirable effects | Aug ,2026 |
| Denosumab | Xgeva | 4.8 Undesirable effects | Aug ,2026 |
| Lixisenatide, insulin glargine | Soliqua | 4.4 Special warnings and precautions for use | Aug ,2026 |
| ATOGEPANT | Aquipta | 4.4 Special warnings and precautions for use 4.8 Undesirable effects section | April, 2026 |
| ATOGEPANT | Aquipta | 4.4 Special warnings and precautions for use 4.8 Undesirable effects section | April, 2026 |
| Sertraline Hydrochloride | Lustral | 4.8 Undesirable effects | April, 2026 |
| Rosuvastatin Calcium, Ezetimibe | Roneza | 4.4 Special Warnings and Special Precautions for Use | Apr,2024 |
| Semaglutide | Rybelsus | 4.4 Special Warnings and Special Precautions for Use | Apr,2024 |
Last update date: 07/09/2026 at 07:51 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.